Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:35:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study record history now includes a version submitted on 2026-10-05 documenting a Study Status update, following the version dated 2026-09-30.
    Difference
    0.4%
    Check dated 2026-10-11T22:25:25.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The history list now shows a new site revision label v3.7.0, replacing the previous v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-20T20:45:12.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    One new revision entry, Revision: v3.6.6, was added to the study history, replacing Revision: v3.6.5 and signaling an update to the record's documentation.
    Difference
    0.1%
    Check dated 2026-08-30T16:02:09.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A newer revision label (v3.6.5) has been added to the history. The previous revision (v3.6.4) has been removed from the history.
    Difference
    0.1%
    Check dated 2026-08-09T00:45:01.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 on the page history, indicating a small update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-07-25T16:59:33.000Z thumbnail image

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.